INmune Bio, Inc. (INMB) vs Mereo BioPharma Group plc - Sponsored ADR (MREO)
INmune Bio, Inc. and Mereo BioPharma Group plc - Sponsored ADR are both Biotechnology companies. INmune Bio, Inc. and Mereo BioPharma Group plc - Sponsored ADR are of similar size ($55.5M and $54.9M). Across the 10 metrics below, INmune Bio, Inc. leads on 6 and Mereo BioPharma Group plc - Sponsored ADR on 4.
Valuation
Profitability
| Metric | INMB | MREO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (74.82%) | (67.85%) | (57.72%) |
| Return on assets | (57.08%) | (57.73%) | (49.22%) |
| Return on invested capital | (646.94%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack